397 related articles for article (PubMed ID: 17478069)
1. Comparison of magnetic resonance imaging and (67)gallium scintigraphy in the evaluation of posttherapeutic residual mediastinal mass in the patients with Hodgkin's lymphoma.
Herman M; Paucek B; Raida L; Myslivecek M; Zapletalová J
Eur J Radiol; 2007 Dec; 64(3):432-8. PubMed ID: 17478069
[TBL] [Abstract][Full Text] [Related]
2. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
[TBL] [Abstract][Full Text] [Related]
3. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvement.
Zinzani PL; Magagnoli M; Franchi R; Zompatori M; Frezza G; Galassi R; Gherlinzoni F; Bendandi M; Albertini P; Monetti N; Tura S
Haematologica; 1999 Jul; 84(7):604-7. PubMed ID: 10406901
[TBL] [Abstract][Full Text] [Related]
5. [Does the residual mediastinal mass have prognostic significance in children with Hodgkin's disease (HD)?].
Klekawka T; Balwierz W; Moryl-Bujakowska A; Stanuch H; Matysiak M; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Chaber R; Sońita-Jakimczyki D; Janik-Moszants A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Adamkiewicz-Drozyińska E; Wysocki M; Koltan A; Krawczuk-Rybako M; Muszyńska-Rosłan K; Stolarska M
Przegl Lek; 2006; 63(1):21-4. PubMed ID: 16892894
[TBL] [Abstract][Full Text] [Related]
6. Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL; Zompatori M; Bendandi M; Battista G; Fanti S; Barbieri E; Gherlinzoni F; Rimondi MR; Frezza G; Pisi P; Merla E; Gozzetti A; Canini R; Monetti N; Babini L; Tura S
Leuk Lymphoma; 1996 Jun; 22(1-2):131-5. PubMed ID: 8724540
[TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance in the study of residual mediastinal masses after therapy of lymphoma].
Davini O; Levis A; Garabello D; Foggetti MD; Depaoli L; Cirillo R; De Lucchi R; Orsucci L; Resegotti L
Radiol Med; 1992 Mar; 83(3):230-6. PubMed ID: 1579671
[TBL] [Abstract][Full Text] [Related]
8. Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Ann Oncol; 1997; 8 Suppl 1():53-6. PubMed ID: 9187430
[TBL] [Abstract][Full Text] [Related]
9. [Does residual mediastinal mass in children with completed treatment of Hodgkin's disease affect the incidence of relapses?].
Balwierz W; Armata J; Moryl-Bujakowska A; Depowska T; Bogusławska-Jaworska J; Pisarek J; Sońta-Jakimczyk D; Janik-Moszant A; Rokicka-Milewska R; Sopyło B; Kołakowska-Mrozowska B; Radwańska U; Kołecki P; Kaczmarek-Kanold M; Kowalczyk J; Skomra S; Ochocka M; Matysiak M; Newecka-Samól T
Wiad Lek; 1998; 51 Suppl 4():12-7. PubMed ID: 10731938
[TBL] [Abstract][Full Text] [Related]
10. Gallium scan in adolescents and children with Hodgkin's disease (HD). Treatment response assessment and prognostic value.
Castellani MR; Cefalo G; Terenziani M; Aliberti G; Maccauro M; Alessi A; Villano C; Bombardieri E
Q J Nucl Med; 2003 Mar; 47(1):22-30. PubMed ID: 12714951
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].
Capua A; Osti MF; Scattoni Padovan F; Sarra R; Sbarbati S; Anselmo AP; Maurizi Enrici R
Radiol Med; 1995 Dec; 90(6):797-803. PubMed ID: 8685466
[TBL] [Abstract][Full Text] [Related]
12. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
[TBL] [Abstract][Full Text] [Related]
13. Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
Advani R; Maeda L; Lavori P; Quon A; Hoppe R; Breslin S; Rosenberg SA; Horning SJ
J Clin Oncol; 2007 Sep; 25(25):3902-7. PubMed ID: 17664458
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
15. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of pelvic and femoral bones for detection of bone marrow infiltration in patients with non-Hodgkins lymphoma.
Al-Mulhim FA
Saudi Med J; 2005 Jan; 26(1):31-6. PubMed ID: 15756349
[TBL] [Abstract][Full Text] [Related]
17. [Bulky mediastinal lymphomas: role of magnetic resonance and SPECT-Ga-67 in the evaluation of residual masses].
Canini R; Battista G; Monetti N; Pisi P; Fanti S; Zinzani PL; Zompatori M; Bendandi M; Gherlinzoni F; Corinaldesi A
Radiol Med; 1995 Oct; 90(4):448-56. PubMed ID: 8552823
[TBL] [Abstract][Full Text] [Related]
18. Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study.
Re A; Ferrari S; Frata P; Pizzocaro C; Crippa C; Tucci A; Facchetti F; Grazioli L; Magrini SM; Rossi G
Ann Oncol; 2008 May; 19(5):951-7. PubMed ID: 18209012
[TBL] [Abstract][Full Text] [Related]
19. Computed tomography, magnetic resonance and gallium 67 scintigraphy for the imaging of residual lymphoma.
Zaja F; Russo D; Silvestri F; Fanin R; Infanti L; Bendini M; Zuiani C; Englaro E; Cattaruzzi E; Guerra UP
Haematologica; 1995; 80(6):569-71. PubMed ID: 8647525
[No Abstract] [Full Text] [Related]
20. Response measurement after intraarterial chemoradiation in advanced head and neck carcinoma: magnetic resonance imaging and evaluation under general anesthesia?
van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Balm AJ
Cancer; 2006 Apr; 106(8):1722-9. PubMed ID: 16544314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
